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Background. Multidimensional preventive home visit programs aim at maintaining health and autonomy of older
adults and preventing disability and subsequent nursing home admission, but results of randomized controlled trials
(RCTs) have been inconsistent. Our objective was to systematically review RCTs examining the effect of home visit
programs on mortality, nursing home admissions, and functional status decline.
Methods. Data sources were MEDLINE, EMBASE, Cochrane CENTRAL database, and references. Studies were
reviewed to identify RCTs that compared outcome data of older participants in preventive home visit programs with
control group outcome data. Publications reporting 21 trials were included. Data on study population, intervention
characteristics, outcomes, and trial quality were double-extracted. We conducted random effects meta-analyses.
Results. Pooled effects estimates revealed statistically nonsignificant favorable, and heterogeneous effects on mortality
(odds ratio [OR] 0.92, 95% confidence interval [CI], 0.80–1.05), functional status decline (OR 0.89, 95% CI, 0.77–1.03),
and nursing home admission (OR 0.86, 95% CI, 0.68–1.10). A beneficial effect on mortality was seen in younger study
populations (OR 0.74, 95% CI, 0.58–0.94) but not in older populations (OR 1.14, 95% CI, 0.90–1.43). Functional decline
was reduced in programs including a clinical examination in the initial assessment (OR 0.64, 95% CI, 0.48–0.87) but not
in other trials (OR 1.00, 95% CI, 0.88–1.14). There was no single factor explaining the heterogenous effects of trials on
nursing home admissions.
Conclusion. Multidimensional preventive home visits have the potential to reduce disability burden among older adults
when based on multidimensional assessment with clinical examination. Effects on nursing home admissions are
heterogeneous and likely depend on multiple factors including population factors, program characteristics, and health care
setting.
Key Words: Aged—Geriatric assessment—Home visit—In-home—Multidimensional geriatric assessment—Older
adults—Preventive home visit.
PREVENTIVE home visit programs have received muchattention in the past two decades and are part of national
policy in several countries, including Denmark and Australia
(1,2). The overarching goal of such programs is to maintain
the health and autonomy of older adults and to prevent dis-
ability and subsequent nursing home admission. Successful
preventive home visit programs may have important implica-
tions for outcomes as well as for resource use and costs.
However, the value of home visitation programs is contro-
versial (2–8). Although some individual trials and several
meta-analyses (2,3,5) suggest that these programs work, there
is uncertainty to what extent they can prevent adverse out-
comes (i.e., nursing home admission, functional status de-
cline, or mortality), which program components are effective,
and which populations are most likely to benefit (4,6–9).
The most recent meta-analysis of multidimensional pre-
ventive home visit programs published in 2002 suggests that
the variation in findings likely stem from varying study
population and individual program characteristics (2). This
previous meta-analysis found that programs were more
effective when study populations had a lower mean age,
when interventions were based on multidimensional geriat-
ric assessment that included a clinical examination, and
when multiple follow-up home visits were offered (2). Yet
an earlier systematic review using different trial inclusion
criteria concluded that there was no clear evidence in favor
of the effectiveness of preventive home visit programs (8).
Adding to this controversy are several new studies pub-
lished since 2002 showing variable effects of home visit
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programs on both outcomes and costs (10–18). Although
meta-analyses and systematic reviews attempt to contribute
to our field of knowledge by synthesizing the literature, vast
differences in trial inclusion/exclusion criteria and dispar-
ities in the characteristics of included trials make results
difficult to interpret.
We performed a systematic review and meta-analysis
using stringent trial inclusion/exclusion criteria, including
recently published trials of preventive home visits, and
taking into account individual trial characteristics (i.e., dose
of intervention, type of personnel, population health status).
We aimed to summarize the effects of preventive home visit
programs on the key outcomes of nursing home admissions,
functional status decline, and mortality, and to identify
characteristics differentiating successful from unsuccessful
programs. Based on findings of the 2002 meta-analysis, we
hypothesized that programs are more likely to be beneficial
on all three outcomes if they include a clinical examination
as part of the initial multidimensional evaluation, are di-
rected to younger study populations, and have more inten-
sive interventions.
METHODS
Literature Search and Eligibility Criteria
We searched for randomized controlled trials (RCTs) of
the effects of multidimensional preventive home visit
programs in older adults (mean age .70 years) living in
the community. Trials had to report at least one of these
outcomes: nursing home admission, functional status de-
cline, or mortality. We evaluated studies included in the
most recently published meta-analyses (2–5). Published
studies were also identified through searches of EMBASE
and MEDLINE (January 2001 through October 2007) and
the Cochrane Database for Systematic Reviews (issue 4,
2007), using key words: aged, home or in-home, prevention,
multidimensional, screening, and geriatric in combination
with functional, nursing home, or mortality). We also
searched the Cochrane Central Register of Controlled Trials
with the same search terms. No language restrictions were
applied. Three reviewers (A.H., A.E.S., and K.M.C.-G.)
independently screened titles, abstracts, and full texts.
Discrepancies were resolved by consensus with a fourth
reviewer (L.Z.R.). We excluded studies that reported post–
hospital discharge programs or home-based care-management
programs, or did not offer broad preventive intervention
programs but instead had a specific therapeutic or rehabili-
tative purpose such as cardiac rehabilitation or treatment
of depression. Only studies designed with follow-up that
included regular contact with intervention participants were
included (i.e., multiple home visits, or home visits with
regular telephone follow-up) (2,19).
Data Extraction and Outcome Definition
We extracted the following information on the study
population and the characteristics of the intervention
program: mean age of study population, dose of intervention
(measured by the mean number of preventive home visits
performed per year), if the initial multidimensional geriatric
assessment included a clinical examination (e.g., physical
examination, blood pressure measurement, foot examination
[for diabetics], or laboratory tests for all intervention
participants), and whether or not a geriatrician was part of
the intervention team.
For each study, two of us (A.H. and K.M.C.-G.) indepen-
dently extracted information on the endpoints nursing home
admissions, functional status, and mortality. We recorded
the number of participants admitted to nursing homes
(excluding when identified short-term nursing home admis-
sions and admissions to residential or board and care units).
We abstracted the number of persons with functional status
decline at follow-up. The definition of functional status was
based on activities of daily living (ADL) or other specific
measures of functional abilities as individually reported [i.e.,
Groningen Activity Restriction Scale-3 (11)]. If several
outcome measures were reported, we used the measure
based on ADLs. Six trials used continuous rather than
discrete outcomes and provided means and standard devia-
tions of these outcomes (11–13,20–22). These results were
converted to odds ratios (OR) by use of the method
described by Chinn (23) and Hasselblad and Hedges (24).
This method is based on the fact that, when assuming
logistic distributions and equal variances in the two treat-
ment groups, the log OR corresponds to a constant multi-
plied by the standardized difference between means. For
mortality, the number of deaths from all causes and par-
ticipants with known vital status were recorded for inter-
vention and control groups.
Original investigators were contacted if published data
on study characteristics were incomplete or if data on any
key outcome (nursing home admissions, functional status,
and mortality) were missing or incomplete. Additional
unpublished information was obtained from nine studies
(10–13,20,21,25–27).
Assessment of Methodological Quality
Two of us (A.H. and K.M.C.-G.) assessed trial quality by
examining the method of randomization and concealment of
allocation, as well as blinding of staff ascertaining outcomes
(28,29).
Statistical Analysis
We used a version of the ‘‘metan’’ command for Stata
statistical software (Stata Corporation, College Station, TX)
to conduct DerSimonian and Laird random effects meta-
analyses (30). Between-trial heterogeneity was quantified
using the I2 statistic, which can be understood as the pro-
portion of the total variation in estimated ORs that is due to
between-trial heterogeneity rather than chance (31).
The extent to which one or more study characteristic
explained between-trial heterogeneity was explored using
meta-regression. The following variables were considered:
mean age (in tertiles 77 years, 78– ,80 years, 80
years), control group mortality rate (per year in tertiles
,0.067, 0.067–0.081, .0.081; indicator of baseline risk of
death and proxy for population health status), dose of
intervention (mean number of visits ,3, 3 per year
dichotomized by median), clinical examination (yes/no),
and whether a geriatrician was involved in the intervention.
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In addition, we assessed effects of methodological quality
characteristics such as concealment of allocation (adequate
vs unclear) and blinding (outcome assessors reported to be
blinded vs unclear). For all outcomes, we included the
variables above one-by-one in meta-regression models, and
conducted random effects meta-analyses within each sub-
group. Systematic differences between small and large trials
were assessed using funnel plots, and a statistical test for
small study effects (funnel plot asymmetry) (32).
RESULTS
Identification of Eligible Trials
We identified 4770 publications in our literature search,
of which 20 publications describing 21 RCTs met our
inclusion criteria and were included in our meta-analysis
(Figure 1).
Characteristics of Trials, Participants, and
Intervention Programs
An overview of study characteristics is given in Table 1.
In the 21 included trials, 14,603 persons were allocated to
either intervention (7355) or control (7248) groups. All
RCTs reported mortality by intervention groups, 16 (76%)
reported nursing home admissions, and 16 (76%) reported
functional decline in a way that we could extract and
compare results between trials. Mean age of the participants
ranged from 73 to 83 years, with a median of 78.0. The
number of home visits ranged up to 12, with a median of
4.3. Duration of the intervention period was reported to be
between 4 months and 4 years. Seven trials (33%) reported
an intervention period of 1 year or less, 14 (67%) reported
a longer period. Six of the 21 trials (29%) reported having
involved a geriatrician in the intervention, and seven trials
(33%) reported an initial multidimensional geriatric assess-
ment that included a clinical examination. Most studies
reported that controls received ‘‘usual care,’’ but 4 of the 21
(19%) trials also reported interventions in controls. These
were telephone follow-ups (20), a home safety visit (14), a
single counselling session (16), or a social worker visit (27).
Effects on Nursing Home Admission
Trial results of nursing home admissions were heteroge-
neous (I2 42.5%, p ¼ .04). The overall reduction in the risk
of admission was modest and not statistically significant,
with a combined OR of 0.86 (95% confidence interval [CI],
0.68–1.10) (Table 2). For none of the study characteristics
hypothesized to influence effects, meta-regression showed
evidence of an association (Table 3). For example,
multidimensional preventive home visit programs with ,3
home visits per year had a similar effect on nursing home
admissions as compared to programs with 3 visits per year
(Figure 2).
Effects on Functional Status
Trial results of functional decline were also heteroge-
neous (I2 52.4%, p ¼ .01). Trials overall had little effect on
functional decline, with a combined OR of 0.89 (95% CI,
0.76–1.03). Of the characteristics hypothesized to be
associated with functional decline, studies including a clin-
ical examination showed a beneficial effect on functional
status with an OR of 0.64 (95% CI, 0.48–0.87), but the other
studies did not (OR 1.00, 95% CI, 0.88–1.14) (Figure 3). In
meta-regression, this factor was statistically significant (p¼
.02), and the inclusion of this term to the meta-analysis
reduced I2 from 52.4% to 31.0%.
Effects on Mortality
As with the previous outcomes, results of mortality were
heterogeneous (I2 35.6%, p¼ .055) with a combined OR of
0.92 (95% CI, 0.80–1.05). Trials with participants with
a mean age in the lowest tertile showed a protective effect of
the intervention on mortality with an OR of 0.74 (95% CI,
0.58–0.94) compared to the trials with mean age in the
upper tertile with an OR of 1.14 (95% CI, 0.90–1.43)
(Figure 4). Age was borderline statistically significant in
a meta-regression analysis (p , .06), and reduced I2 from
35.6% to 12.6%.
Methodological Quality of Trials
Eleven of 21 (52%) trials reported adequate blinding in
assessing nursing home admissions, and 10 of 21 (48%)
adequate blinding in assessing functional decline. All-cause
mortality is an unambiguous outcome, and blinding of
assessors was not extracted. Concealment of allocation was
Figure 1. Identification of 21 eligible randomized control trials (RCTs) on
multidimensional preventive home visit programs in community-dwelling older
adults.
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assessed to be adequate in 6 of 21 RCTs (29%). In meta-
regression analysis and stratified subgroup analyses (Table
3), there was little evidence that blinding or allocation
concealment influenced results. The funnel plots and
statistical tests for small study effects that were conducted
for all outcomes did not reveal evidence of funnel plot
asymmetry (all p . .2).
DISCUSSION
This systematic review and meta-analysis of multidi-
mensional preventive home visit programs in community-
dwelling older adults using stringent inclusion criteria
showed heterogeneous results for all outcomes. Meta-
regression analyses confirmed our hypotheses related to
functional status and mortality outcomes. Preventive home
visit programs focusing on younger study populations
produced significant beneficial effects on mortality, and
programs prevented or significantly delayed functional
status decline if they included a clinical examination as
part of the initial assessment. However, this meta-analysis
did not confirm our hypotheses related to nursing home
admissions, and no effect on any outcome was seen in pro-
grams with more intensive interventions.
In the nearly 6 years since the most recent meta-analysis
on preventive home visit programs was conducted (2),
several new studies have been published, adding to the
evidence base (10–16,33,34). We included these new RCTs,
evaluated additional study characteristics, and used more
stringent study inclusion criteria. Our methods confirmed
some previous findings and provided some surprising new
ones. We confirmed that the use of multidimensional
geriatric assessment that included a clinical examination
and regular follow-up was an important determinant of
program effects on functional status outcomes. This finding
is compatible with the concept that functional status decline
can be delayed or prevented by periodic multidimensional
evaluation for detection of modifiable risk factors and
subsequent long-term intervention to modify these risk
factors as well as to identify new risks. Also consistent with
previous research, the effect of preventive home visit
programs on mortality was most pronounced in younger
populations.
Our results showed no program effects on nursing home
admissions among older adults, even in trials with intensive
interventions. Heterogeneity between trials was large, with
results ranging from a statistically significant reduction in
nursing home admissions (OR 0.39, 95% CI, 0.17–0.88)
(35) to a significant increase in nursing home admissions as
a result of the preventive home visits (OR 2.81, 95% CI,
1.22–6.46) (10). The fact that nursing home admissions
might even be increased as a result of preventive home visits
in some trials might be explained by regional health care
factors, perhaps related to an underlying under provision of
nursing home care, with appropriate placements of older
persons to nursing homes as a result of the intervention.
Alternatively, other factors such as unmeasured intervention
quality factors might be responsible for these variable
effects (36).
A major strength of this research is that we conducted an
extensive and thorough literature search: We are confident
that we identified all published RCTs meeting our inclusion
Table 2. Odds Ratios for Nursing Home Admission, Functional Status Decline, and Mortality in
21 Trials (Listed Alphabetically) of Multidimensional Preventive Home Visit Programs for
Community-Dwelling Older Adults
Study (Author, Y, Ref)
Nursing Home Admission
OR (95% CI)
Functional Status Decline
OR (95% CI)
Mortality
OR (95% CI)
Bouman et al., 2007 (12) 0.96 (0.40–2.33) 0.97 (0.66–1.44) 1.41 (0.78–2.57)
Byles et al., 2004 (10) 2.81 (1.22–6.46) 1.10 (0.92–1.32) 1.29 (0.93–1.79)
Carpenter and Demopoulos, 1990 (25) 0.67 (0.28–1.59) 1.02 (0.68–1.55) 1.26 (0.84–1.90)
Fabacher et al., 1994 (20) —* 0.56 (0.34–0.94) 0.95 (0.23–3.91)
Gunner-Svensson et al., 1984 (46) 0.81 (0.65–1.01) —* 1.03 (0.89–1.19)
Hebert et al., 2001 (47) 1.02 (0.29–3.56) 0.96 (0.62–1.51) 0.66 (0.31–1.40)
Hendriksen et al., 1984 (26) 0.67 (0.37–1.22) —* 0.73 (0.50–1.08)
Kono et al., 2004 (13) 0.60 (0.18–1.96) 0.83 (0.54–1.29) 0.65 (0.17–2.45)
Mahoney et al., 2007 (14) 0.55 (0.36–0.86) —* 1.14 (0.43–3.02)
Melis et al., 2008 (11) 0.83 (0.39–1.76) 1.24 (0.69–2.23) 0.97 (0.25–3.76)
Pathy et al., 1992 (48) 0.67 (0.37–1.22) 1.24 (0.76–2.03) 0.70 (0.49–1.00)
Sahlen et al., 2006 (15) —* —* 0.81 (0.54–1.20)
Sjosten et al., 2007 (16) —* —* 1.28 (0.34–4.80)
Stuck et al., 1995 (35) 0.39 (0.17–0.88) 0.48 (0.26–0.88) 0.84 (0.46–1.51)
Stuck et al., 2000 (36) 1.58 (0.99–2.54) 0.80 (0.53–1.19) 1.49 (0.99–2.23)
Tinetti et al., 1994 (27) 0.48 (0.04–5.35) 0.42 (0.23–0.76) 1.37 (0.43–4.42)
van Haastregt et al., 2000 (21) 0.97 (0.06–15.62) 0.68 (0.43–1.06) 0.67 (0.29–1.56)
van Rossum et al., 1993 (22) 1.39 (0.44–4.43) 1.16 (0.86–1.56) 0.80 (0.51–1.25)
Vetter et al. (Gwent), 1984 (49) —* 1.32 (0.92–1.91) 0.53 (0.34–0.83)
Vetter et al. (Powys), 1984 (49) —* 0.69 (0.47–1.02) 0.96 (0.61–1.51)
Vetter et al., 1992 (50) 1.44 (0.58–3.57) 0.87 (0.60–1.26) 0.69 (0.49–0.97)
Combined odds ratio (random effects) 0.86 (0.68–1.10) 0.89 (0.77–1.03) 0.92 (0.80–1.05)
I2, p value, test of heterogeneity 42.5%, p ¼ .037 52.4%, p ¼ .008 35.6%, p ¼ .055
Notes: *Outcome not assessed.
OR ¼ odds ratio; CI ¼ confidence interval.
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criteria. We collected detailed information on study charac-
teristics (e.g., population health status, dose of intervention,
assessment domains, intervention personnel), which allowed
a more extensive evaluation of the effect of study popula-
tion and program characteristics on outcomes. We also
purposely used stringent inclusion criteria based on previous
research, thereby attempting to reduce some of the variation
in program characteristics (2). This meant that we excluded
some studies that had been included in the previous meta-
analysis as well as some larger newer trials (33,34,37–40).
A recent study in Denmark was excluded because it was
primarily a study of provider education (34). Moreover,
we excluded the large Medical Research Council (MRC)
trial (33), because intervention assessments were not only
offered to persons in the intervention group (‘‘universal
assessment group’’), but also to persons in the control group
(‘‘targeted assessment group’’), and the intervention did
not include home visits with regular follow-up. The results
of the MRC trial were disappointing, with few differences at
the 3-year follow-up. One hypothesis is that the intervention
in the control group might have diluted intervention effects.
A second hypothesis is that, although the MRC trial is the
largest trial of geriatric assessment ever done, the random-
ization of general practices rather than individuals means
that it may not have had sufficient statistical power to detect
or exclude clinically important effects (41).
There is widespread confusion regarding terminology.
We suggest the use of the term ‘‘multidimensional pre-
ventive home visit program’’ for home visit programs
offered to community-dwelling older adults (rather than
selected groups of older people, such as to those recently
discharged from the hospital), with follow-up through home
visits or telephone contacts (rather than screening-only
programs or home-based care-management programs) that
include multidimensional assessment. Lack of uniform
terminology has led to confusion over program definition
and probably contributed to the heterogeneity in results. The
use of clearly defined terminology will help to develop
Table 3. Random Effects Meta-Analyses for Outcomes Nursing Home Admission, Adverse Functional Status, and
Mortality Stratified by Study Characteristics in 21 Trials of Multidimensional Preventive Home
Visit Programs for Community-Dwelling Older Adults
Characteristics
Nursing Home Admission
OR (95% CI)
Functional Status Decline
OR (95% CI)
Mortality
OR (95% CI)
Study characteristics*
Population
Mean age of study population (in tertiles)
77 y 0.87 (0.57–1.34) 0.91 (0.71–1.18) 0.74 (0.58–0.94)jj
78–,80 y 1.03 (0.62–1.71) 0.85 (0.60–1.56) 0.97 (0.84–1.12)
80 y 0.75 (0.49–1.16) 0.87 (0.70–1.08) 1.14 (0.90–1.43)
Mortality rate in controls (per y in tertiles)
,0.067 1.15 (0.59–2.25) 0.92 (0.74–1.55) —z
0.067–0.081 0.78 (0.64–0.94) 0.81 (0.60–1.10) —z
.0.081 0.78 (0.52–1.17) 0.94 (0.71–1.24) —z
Intervention program
Multidimensional assessment with clinical examination
No 0.88 (0.70–1.11) 1.00 (0.88–1.14)y 0.88 (0.76–1.03)
Yes 0.75 (0.39–1.44) 0.64 (0.48–0.87) 1.13 (0.86–1.48)
Geriatrician involved in intervention
No 0.88 (0.70–1.09) 0.94 (0.81–1.09) 0.88 (0.76–1.02)
Yes 0.75 (0.40–1.42) 0.72 (0.50–1.05) 1.20 (0.90–1.61)
Dose of intervention (dichotomized by median)
,3 visits per y 0.90 (0.62–1.32) 0.98 (0.84–1.15) 0.91 (0.76–1.09)
3 visits per y 0.85 (0.60–1.19) 0.81 (0.63–1.03) 0.92 (0.74–1.14)
Methodological quality characteristics
Concealment of allocation
Adequate 0.71 (0.35–1.42) 0.69 (0.54–0.88) 1.18 (0.88–1.58)
Unclear 0.88 (0.71–1.08) 0.96 (0.83–1.12) 0.88 (0.76–1.02)
Blinding of staff ascertaining outcomes
Blinded 0.97 (0.67–1.42) 0.87 (0.72–1.05) —§
Unclear 0.75 (0.61–0.92) 0.92 (0.71–1.19) —§
Notes: *For definition of characteristics, see Methods section.
yVariable statistically significant (p , .05) in meta-regression analysis.
zOutcome not analyzed, stratified variable same as outcome variable.
§Stratification variable not assessed.
jjVariable borderline statistically significant (p , .06) in meta-regression analysis.
OR ¼ odds ratio; CI ¼ confidence interval.
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a consensus and standardize program characteristics in the
field. This definition differentiates preventive home visit
programs from other potentially promising intervention
programs that are offered in the home setting for older
adults. For instance, a recently published RCT in the United
States described beneficial effects of a home-based geriatric
care-management program offered to a population of low-
income older adults (42).
Based on RCTs, the comparisons made in meta-
regression analyses are observational, and factors included
in the meta-regression analyses might not be independent.
Meta-analytic subgroup analyses, like subgroup analyses
Figure 2. Effect of multidimensional preventative home visit programs on nursing home admissions, trials stratified by number of visits per year (,3 visits per year,
3 visits per year), random effects model.
Figure 3. Effect of multidimensional preventative home visit programs on functional status decline, trials stratified by multidimensional assessment with clinical
examination, random effects model.
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within trials, are prone to bias and confounding and
therefore should be interpreted with caution (43–45). There
is also inaccuracy in meta-analysis results due to poor
individual trial reporting and imprecision in measurement,
which might result in nondifferential misclassification and
potential underestimates of true effects. This might be an
issue for the functional decline outcomes that were
measured using different methods and may have been
affected by attrition bias. Although we assessed population
and intervention characteristics, these measures were
limited. For example, we were unable to find a precise
measure of the intervention dose and therefore had to use
a crude proxy measure (number of visits per year) that does
not take into account actual content and extent of participant
contacts (i.e., many interventions included inconsistently
described phone contacts). Lastly, we acknowledge that the
effects of other unmeasured program characteristics, such as
the intervention teams’ case loads, scope of practice during
follow-up, interactions with primary care physicians, and
authority to take diagnostic and therapeutic action, could not
be addressed.
The evidence on the effectiveness of multidimensional
preventive home visit programs indicates that even under
controlled experimental conditions, effects of programs vary
and are affected by four major factors: (i) intervention
program characteristics (i.e., nonstandardized terminology
and protocols, nonspecific measures unrepresentative of
actual intensity), (ii) population characteristics (i.e., what
people enrolled, assessed using crude proxy measures), (iii)
adherence (i.e., how participants and health professionals
followed recommendations), and (iv) setting (i.e., underly-
ing patterns of health care use). These results, although
confirming some previous results (2,8), underscore the need
for additional RCTs, collaborative individual person data
(IPD) meta-analyses, as well as practice implementation
programs. Future high-quality trials with well-documented
interventions, follow-up periods, target populations, specific
measures of intervention dose, and exact characterization of
settings would extend our knowledge by further clarifying
which populations benefit and what program characteristics
are effective. Collaborative IPD meta-analyses of existing
trials could also help to distinguish factors related to
programs, populations, intervention dose, and settings.
Based on current evidence, multidimensional preventive
home visits have the potential to reduce disability burden
among older adults. The high prevalence of coexisting risk
factors in community-dwelling older adults emphasizes the
need for multidimensional preventive home visit programs
that address multiple coexisting risk factors. Several
seminal studies have documented the ability of prototype
programs to produce important beneficial effects. By
omitting crucial program components, subsequent replica-
tion trials may produce disappointing results. Therefore,
based on the existing body of evidence, future programs
should be tailored to specific regional settings, and effects
of programs on health and health care use should be
evaluated in the real clinical practice settings in which they
function.
Figure 4. Effect of multidimensional preventative home visit programs on mortality, trials stratified by three age groups (years in tertiles), random effects model.
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